Will Aslan Pharmaceuticals Ltd (ASLN) Stay at the Top of the Healthcare Sector?

Aslan Pharmaceuticals Ltd (ASLN) is around the top of the Healthcare sector according to InvestorsObserver. ASLN received an overall rating of 28, which means that it scores higher than 28% of stocks. Additionally, Aslan Pharmaceuticals Ltd scored a 78 in the Healthcare sector, ranking it higher than 78% of stocks in that sector.

ASLN has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on ASLN!

See Full ASLN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aslan Pharmaceuticals Ltd Stock Today?

Aslan Pharmaceuticals Ltd (ASLN) stock is down -1.92% while the S&P 500 has risen 0.08% as of 1:25 PM on Friday, Sep 10. ASLN has fallen -$0.06 from the previous closing price of $3.12 on volume of 322,291 shares. Over the past year the S&P 500 has risen 34.66% while ASLN has risen 101.32%. ASLN lost -$0.44 per share the over the last 12 months. Click Here to get the full Stock Report for Aslan Pharmaceuticals Ltd stock.